ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Bioqual Inc (PK)

Bioqual Inc (PK) (BIOQ)

60.00
0.00
(0.00%)
Closed February 28 4:00PM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
60.00
Bid
52.00
Ask
60.00
Volume
-
0.00 Day's Range 0.00
60.00 52 Week Range 80.00
Market Cap
Previous Close
60.00
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
205
Shares Outstanding
894,416
Dividend Yield
0.83%
PE Ratio
111.11
Earnings Per Share (EPS)
0.54
Revenue
58.59M
Net Profit
483k

About Bioqual Inc (PK)

BIOQUAL, Inc. is committed to providing quality research, model development, pre-clinical, testing/assay, and consulting services to commercial clients and Government laboratories. BIOQUAL, Inc. is committed to providing quality research, model development, pre-clinical, testing/assay, and consulting services to commercial clients and Government laboratories.

Sector
Coml Physical, Biologcl Resh
Industry
Coml Physical, Biologcl Resh
Website
Headquarters
Wilmington, Delaware, USA
Founded
-
Bioqual Inc (PK) is listed in the Coml Physical, Biologcl Resh sector of the OTCMarkets with ticker BIOQ. The last closing price for Bioqual (PK) was $60. Over the last year, Bioqual (PK) shares have traded in a share price range of $ 60.00 to $ 80.00.

Bioqual (PK) currently has 894,416 shares outstanding. The market capitalization of Bioqual (PK) is $53.66 million. Bioqual (PK) has a price to earnings ratio (PE ratio) of 111.11.

BIOQ Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40060606027860CS
12-6.1-9.2284417549266.166.16020562.41449511CS
26-10-14.285714285770706023865.18923465CS
52-15-2075806029170.2015936CS
156-30-33.3333333333901045744071.97522793CS
26023.4482758620758108.545.548174.23657287CS

BIOQ - Frequently Asked Questions (FAQ)

What is the current Bioqual (PK) share price?
The current share price of Bioqual (PK) is $ 60.00
How many Bioqual (PK) shares are in issue?
Bioqual (PK) has 894,416 shares in issue
What is the market cap of Bioqual (PK)?
The market capitalisation of Bioqual (PK) is USD 53.66M
What is the 1 year trading range for Bioqual (PK) share price?
Bioqual (PK) has traded in the range of $ 60.00 to $ 80.00 during the past year
What is the PE ratio of Bioqual (PK)?
The price to earnings ratio of Bioqual (PK) is 111.11
What is the cash to sales ratio of Bioqual (PK)?
The cash to sales ratio of Bioqual (PK) is 0.92
What is the reporting currency for Bioqual (PK)?
Bioqual (PK) reports financial results in USD
What is the latest annual turnover for Bioqual (PK)?
The latest annual turnover of Bioqual (PK) is USD 58.59M
What is the latest annual profit for Bioqual (PK)?
The latest annual profit of Bioqual (PK) is USD 483k
What is the registered address of Bioqual (PK)?
The registered address for Bioqual (PK) is 251 LITTLE FALLS DRIVE, NEW CASTLE, WILMINGTON, DELAWARE, 19808
What is the Bioqual (PK) website address?
The website address for Bioqual (PK) is www.bioqual.com
Which industry sector does Bioqual (PK) operate in?
Bioqual (PK) operates in the COML PHYSICAL, BIOLOGCL RESH sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
STTOSITO Mobile Ltd (CE)
$ 0.02
(1,999,900.00%)
278
NLVVFNew Leaf Ventures (CE)
$ 0.0089
(889,900.00%)
6.92k
AAGRAfrican Agriculture Holdings Inc (CE)
$ 0.008
(799,900.00%)
101
ETBIEastgate Biotech Corporation (CE)
$ 0.0045
(449,900.00%)
2k
VWESQVintage Wine Estates Inc (CE)
$ 0.002
(199,900.00%)
3.44k
NEXINexImmune Inc (CE)
$ 0.0001
(-99.90%)
13.59k
JERTQJER Investors Trust Inc New (CE)
$ 0.000001
(-99.67%)
10k
AGILQAgileThought Inc (CE)
$ 0.0001
(-99.10%)
4.7k
GAYGFMontauk Metals Inc (PK)
$ 0.0012
(-99.08%)
6.25k
IONMAssure Holdings Corporation (CE)
$ 0.000001
(-99.00%)
112
HMBLHUMBL Inc (PK)
$ 0.0005
(25.00%)
279.83M
AITXArtificial Intelligence Technology Solutions Inc (PK)
$ 0.0026
(-3.70%)
123.47M
SPQSSportsQuest Inc (PK)
$ 0.0001
(-50.00%)
114.57M
BOMObowmo Inc (PK)
$ 0.0001
(0.00%)
102.85M
VTXBVortex Brands Company (PK)
$ 0.0001
(0.00%)
101.18M

BIOQ Discussion

View Posts
AskMuncher AskMuncher 4 years ago
$BIOQ BIOQUAL Presents Financial Results for Fiscal Year 2020 and Declares Dividend
Press Release | 09/15/2020
BIOQUAL ((OTC Pink: BIOQ) (www.bioqual.com):



2020




2019




Revenue

$

46,360,201


$

39,478,079




Income Before Income Tax

$

5,488,938


$

3,709,246




Net Income

$

4,230,938


$

2,830,875




Basic Earnings per Share








of Common Stock

$

4.74


$

3.17


Diluted Earnings per Share








of Common Stock

$

4.73


$

3.17


Weighted Average








Number of Shares Outstanding






For Basic Per Share



893,416




893,416


Weighted Average








Number of Shares Outstanding






For Diluted Earnings Per Share



893,971




893,655

BIOQUAL’s Board of Directors has declared a dividend of $1.10 per share for shareholders of record on September 28, 2020, payable on October 21, 2020. This is the nineteenth dividend declared by BIOQUAL.

Statements herein that are not descriptions of historical facts are forward-looking and subject to risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors including risks relating to the ability to continue to extend current government contracts; the Company’s ability to obtain new government or commercial contracts; continued demand for the use of animal models in scientific research; the Company’s ability to perform under its contracts in accordance with the requirements of the contracts; the actual costs incurred in performing the Company’s contracts and its ability to manage its costs, including its capital expenditures; dependence on third parties; future capital needs; the ability to fund its capital needs through the use of its cash on hand and line of credit; and the future availability and cost of financing/capital sources to the Company.


View source version on businesswire.com: https://www.businesswire.com/news/home/20200915005969/en/
👍️0
Ubertino Ubertino 10 years ago
Get on a decent exchange!

Too easily to manipulate as an OTC-Pinky!

Get on a decent exchange - NYSE or affiliate - then I might be interested.
👍️0